December 18, 2008 - Boston Scientific Corp. today announced enrollment of the first patient in the CABANA post-market approval study of the company’s Carotid WALLSTENT Monorail Endoprosthesis used in conjunction with its FilterWire EZ Embolic Protection System.

The first patient was enrolled in the CABANA Study by Rajesh M. Dave, M.D., chairman, endovascular medicine, Pinnacle Health Heart and Vascular Institute, Harrisburg Hospital, Harrisburg, PA.

December 18, 2008 - Abbott this week said it started the SPIRIT Small Vessel, a clinical trial evaluating a 2.25mm size of the XIENCE V Everolimus-Eluting Coronary Stent System.

The 2.25mm stent system would offer physicians an option for treating coronary artery disease in narrower vessels that is based on the proven efficacy, safety and deliverability of XIENCE V.

December 18, 2008 - Spectranetics Corp. this week said the FDA cleared the Cross-Pilot Laser Support Catheter used in ablation of arterial blockages.

The launch of the product will commence during the first quarter of 2009 in the U.S., Europe and Canada.

December 17, 2008 – Yesterday’s agreement between Spacelabs Healthcare and Uscom gives Spacelabs exclusive distribution of the USCOM 1A ultrasonic cardiac output monitor in the Americas, Europe, Middle East, Africa and India.

December 17, 2008 – In the latest MD Buyline survey, GE Healthcare Monitoring Solutions and Diagnostic Cardiology Services, which includes service for patient, telemetry and Holter monitors as well as cardiac stress, cardiology management and electrocardiograph systems, achieved higher rankings nearly across the board.

December 17, 2008 - Bioheart Inc. announced yesterday its plan to shift focus from several non-core technology platforms to concentrate on the treatment of patients suffering from heart failure.

Bioheart will spin out or sell off its interest in several non-core technology platforms to which it holds the rights to multiple patents and patents pending related to these non-core technologies as well as proprietary know-how and trade secrets. Animal data supporting the proof of concept for some of these technologies is also available from the company.

December 16, 2008 - Rcadia Medical Imaging Ltd., developer of the COR Analyzer software for the automated analysis of coronary CT angiography (CCTA) studies, closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA.

December 15, 2008 - The FDA has approved Abbott's TRILIPIX (fenofibric acid) delayed-release capsules, the first and only fibrate indicated for use in combination with a statin for cholesterol management.

The drug is indicated for use along with diet to help lower triglycerides and LDL cholesterol, and to raise HDL cholesterol in patients with lipid problems. In certain patients, treatment guidelines recommend the combination of a fibrate with a statin to further improve lipid levels. TRILIPIX has not been shown to prevent heart disease or heart attack.

December 16, 2008 - New data from a retrospective, multicenter, cohort study of over four million hospitalized patients shows similar unadjusted mortality rates for patients receiving DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.

Study findings were published in the December 2008 issue of The American Journal of Cardiology.

December 16, 2008 – Digisonics was awarded the Best in KLAS for the cardiology market segment in the 2008 Top 20 Best in KLAS Awards report published this week.

The KLAS evaluation is comprised of 40 individual questions that cover everything from contracting and sales to implementation, service and upgrades.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now